These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16979589)

  • 21. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products.
    Levonen AL; Landar A; Ramachandran A; Ceaser EK; Dickinson DA; Zanoni G; Morrow JD; Darley-Usmar VM
    Biochem J; 2004 Mar; 378(Pt 2):373-82. PubMed ID: 14616092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
    Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
    Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH; Surh YJ
    Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K; Sánchez-Gómez FJ; Pérez-Sala D
    J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M; Maeyama K
    Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
    Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
    Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
    Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
    Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads.
    Maekawa N; Hiramoto M; Sakamoto S; Azuma M; Ito T; Ikeda M; Naitou M; Acharya HP; Kobayashi Y; Suematsu M; Handa H; Imai T
    Biomed Chromatogr; 2011 Apr; 25(4):466-71. PubMed ID: 21374648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression.
    Liu JD; Tsai SH; Lin SY; Ho YS; Hung LF; Pan S; Ho FM; Lin CM; Liang YC
    Life Sci; 2004 Mar; 74(19):2451-63. PubMed ID: 14998722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2.
    Gong P; Stewart D; Hu B; Li N; Cook J; Nel A; Alam J
    Antioxid Redox Signal; 2002 Apr; 4(2):249-57. PubMed ID: 12006176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of monoclonal antibody for 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂ and development of enzyme-linked immunosorbent assay for its quantification in culture medium of adipocytes.
    Syeda PK; Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1107-18. PubMed ID: 22391692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glutathionylation of p65 modulates NF-κB activity in 15-deoxy-Δ¹²,¹⁴-prostaglandin J₂-treated endothelial cells.
    Lin YC; Huang GD; Hsieh CW; Wung BS
    Free Radic Biol Med; 2012 May; 52(9):1844-53. PubMed ID: 22387200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
    Kamagata C; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2007 May; 102(3):263-73. PubMed ID: 17028981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells.
    Wung BS; Wu CC; Hsu MC; Hsieh CW
    Life Sci; 2006 May; 78(26):3035-42. PubMed ID: 16413037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actin Cys374 as a nucleophilic target of alpha,beta-unsaturated aldehydes.
    Dalle-Donne I; Carini M; Vistoli G; Gamberoni L; Giustarini D; Colombo R; Maffei Facino R; Rossi R; Milzani A; Aldini G
    Free Radic Biol Med; 2007 Mar; 42(5):583-98. PubMed ID: 17291982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of yeast F-actin structure by a mutation in the nucleotide-binding cleft.
    Orlova A; Chen X; Rubenstein PA; Egelman EH
    J Mol Biol; 1997 Aug; 271(2):235-43. PubMed ID: 9268655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification.
    Garzón B; Gayarre J; Gharbi S; Díez-Dacal B; Sánchez-Gómez FJ; Timms JF; Pérez-Sala D
    Chem Biol Interact; 2010 Jan; 183(1):212-21. PubMed ID: 19800325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.